Advertisement
Advertisement

TDOC

TDOC logo

Teladoc Health, Inc.

5.52
USD
Sponsored
-0.05
-0.93%
Mar 26, 15:59 UTC -4
Closed
exchange

After-Market

5.54

+0.02
+0.31%

TDOC Earnings Reports

Positive Surprise Ratio

TDOC beat 25 of 41 last estimates.

61%

Next Report

Date of Next Report
Apr 28, 2026
Estimate for Q1 26 (Revenue/ EPS)
$626.28M
/
-$0.31
Implied change from Q4 25 (Revenue/ EPS)
-2.49%
/
+121.43%
Implied change from Q1 25 (Revenue/ EPS)
-0.49%
/
-41.51%

Teladoc Health, Inc. earnings per share and revenue

On Feb 25, 2026, TDOC reported earnings of -0.14 USD per share (EPS) for Q4 25, beating the estimate of -0.19 USD, resulting in a 26.89% surprise. Revenue reached 642.27 million, compared to an expected 647.94 million, with a -0.88% difference. The market reacted with a +15.05% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 21 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 626.28 million USD, implying an increase of 121.43% EPS, and decrease of -2.49% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
logo
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
logo
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
logo
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
logo
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
logo
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
logo
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
logo
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
For Q4 2025, Teladoc Health, Inc. reported EPS of -$0.14, beating estimates by 26.89%, and revenue of $642.27M, -0.88% below expectations.
The stock price moved up 15.05%, changed from $4.65 before the earnings release to $5.35 the day after.
The next earning report is scheduled for Apr 28, 2026.
Based on 21 analysts, Teladoc Health, Inc. is expected to report EPS of -$0.31 and revenue of $626.28M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement